Perrigo | PRGO - Assets



Perrigo reported $10.09B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
AbbVie USD 136.17B 1B Mar/2025
Abbott USD 84B 2.55B Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Corcept Therapeutics USD 801.72M 44.73M Jun/2025
Dr.Reddys Laboratories INR 519.54B 25.27B Jun/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Merck USD 117.52B 2.4B Jun/2025
Nestle CHF 130.12B 9.14B Jun/2025
Pacira USD 1.54B 49.41M Jun/2025
Perrigo USD 10.09B 334.3M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Prestige Brands USD 3.43B 29.41M Jun/2025
Reckitt Benckiser GBP 25.3B 1.11B Dec/2024
Sanofi 124.96B 6.93B Jun/2025
Supernus Pharmaceuticals USD 1.38B 35.11M Jun/2025
Teva Pharmaceutical Industries USD 40.13B 1.72B Jun/2025
Xeris Pharmaceuticals USD 334.69M 11.63M Jun/2025
Zoetis USD 14.48B 381M Jun/2025